ESR1 and neoplasm: In the current study, we evaluated tumor response to treatment with CT, RT, and surgery and compared differences in the clinical process, tumor characteristics, and prognosis among the four subtypes, namely ER-/PR-, ER+/PR-, ER-/PR+, and ER+/PR+.